H.R. 2296 · 116th Congress

Fair Accountability and Innovative Research Drug Pricing Act of 2019

Stage
Reported from committee
Sponsor
Jan Schakowsky
Introduced
2019-04-12
Latest action
2019-09-24 · Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-215.

Subjects

Congressional oversight
Government studies and investigations
Health
Civil actions and liability
Inflation and prices
Medical research
Research and development
Government information and archives
Consumer affairs
Prescription drugs
Corporate finance and management